|
|
|
|
| LEADER |
02636nam a2200337 u 4500 |
| 001 |
EB001839828 |
| 003 |
EBX01000000000000001003817 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a MI - secondary prevention
|h Elektronische Ressource
|b secondary prevention in primary and secondary care for patients following a myocardial infarction
|c National Clinical Guideline Centre ; commissioned by the National Institute for Health and Care Excellence
|
| 246 |
3 |
1 |
|a Secondary prevention of myocardial infarction
|
| 246 |
3 |
1 |
|a Myocardial infarction, secondary prevention
|
| 260 |
|
|
|a London
|b Royal College of Physicians
|c 2013, November 2013
|
| 300 |
|
|
|a 1 PDF file (604 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Comparative Effectiveness Research
|
| 653 |
|
|
|a Secondary Prevention / methods
|
| 653 |
|
|
|a Coronary Artery Disease / prevention & control
|
| 653 |
|
|
|a Myocardial Infarction / prevention & control
|
| 653 |
|
|
|a Treatment Outcome
|
| 710 |
2 |
|
|a Royal College of Physicians of London
|
| 710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a NICE clinical guidelines
|
| 500 |
|
|
|a Title from PDF title page. - "Partial update of NICE CG48, methods, evidence and recommendations.". - Preceded by Post myocardial infarction / National Collaborating Centre for Primary Care (UK). London : Royal College of General Practitioners (UK), c2007
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK247688
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Myocardial infarction (MI) remains one of the most dramatic presentations of coronary artery disease (CAD). Complete occlusion of the artery often produces myocardial necrosis and the classical picture of a heart attack with severe chest pain, electrocardiographic (ECG) changes of ST-segment elevation, and an elevated concentration of myocardial specific proteins in the circulation. Such people are described as having a ST-segment elevation myocardial infarction (STEMI). Intermittent or partial occlusion produces similar, but often less severe clinical features, although no or transient and undetected ST elevation. Such cases are described as a non-ST segment elevation myocardial infarction (NSTEMI). People who have suffered from either of these conditions are amenable to treatment to reduce the risk of further MI or other manifestations of vascular disease, secondary prevention
|